97% of drug candidates in oncology fail in clinical trials. HCS Pharma has developed human 3D cellular model including the matricial microenvironment, in order to better select drug candidates. This model is available for High Content Screening as a service on our Robotic Platform.
Our solution:
BIOMIMESYS® hydroscaffold™ is a hyaluronic acid-based matrix, grafted with structural and adhesion proteins, which mimics the extracellular matrix. Its composition and stiffness can be modulated to reproduce the matrix of any tissue in health or disease.
3D assessment in BIOMIMESYS® ensures a high predictability and a relevant selection of drug candidates.
Pick and choose your cellular model
Pick and choose your read-outs
